BOS Events: BOS Advert

Finish Dosage Contract Development and Medicines Manufacturing

Delpharm is a leading CDMO : - 19 plants in France, Italy, Canada, Poland and The Netherlands - Over 1,1 billion euros turnover - 6,500 people working in the company - Most dosage forms produced For over 35 years, Delpharm has built up its position by acquiring manufacturing plants over the years, in particular from big pharmaceutical companies. As multi-specialists, Delpharm is able to supply the majority of pharmaceutical forms available on the market, such as tablets and capsules, bottles and injectable ampoules, prefilled syringes, freeze-drying, suspensions, solutions, ointments and soft gel capsules. Delpharm also offers full development services for a wide range of pharmaceutical forms, chemical entities and innovative combinations, including the production of phase 1 to 3 clinical batches for solid, semi-solid, liquid and injectable forms.

Link: https://www.delpharm.com/en/

Type: New Service / Capability

Category: CMC: Biologics, Drug Product
CMC: Biologics, Analytical
CMC: Biologics, Packaging
CMC: Small Molecules, Drug Product
CMC: Small Molecules, Analytical
CMC: Small Molecules, Packaging

Hashtags: #ampoules, #analyticaldevelopment, #analytics, #cdmo, #clinical, #clinicalfilling, #clinicalscale, #clinicaltrials, #development, #drugproductdevelopment, #earlystagedevelopment, #formulationdevelopment, #lyophilized, #oralsoliddoses, #pfs, #solidformdevelopment, #sterilemanufacturing, #vials